Skip to main content

Advertisement

Table 2 Frequency of intestinal parasites among the different regimens used with renal transplant recipients

From: Enteroparasitosis infections among renal transplant recipients in Khartoum state, Sudan 2012–2013

Treatment E. H/D E. C C. P G. L E. V H. N A. L S. S Total
Cyclosporine with Cortisone 3 (27.3%) 5 (45.5%) 0 (0.0%) 2 (18.2%) 0 (0.0%) 0 (0.0%) 1 (9.1%) 0 (0.0%) 11 (17.2%)
Cyclosporine with Azathioprine 11 (39.3%) 5 (17.9%) 3 (10.7%) 6 (21.4%) 1 (3.6%) 1 (3.6%) 0 (0.0%) 1 (3.6%) 28 (43.8%)
Tacrolimus combined with Mycophenolate mofetil 8 (44.4%) 10 (55.6%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 18 (28.1%)
Cyclosporine combined with Cortisone and Mycophenolate mofetil 2 (28.6%) 1 (14.3%) 2 (28.6%) 1 (14.3%) 0 (0.0%) 0 (0.0%) 1 (14.3%) 0 (0.0%) 7 (10.9%)
Total 24 (37.5%) 21 (32.8%) 5 (7.8%) 9 (14.0%) 1 (1.6%) 1 (1.6%) 2 (3.1%) 1 (1.6%) 64 (100%)
  1. E. H/D: Entamoeba histolytica/dispare, E. C: Entamoeba coli, C. P: Cryptosporidium parvum, G. L: Giardia lambelia, E. V: Enterobius vermicularis, H. N: Hymenolepis nana, A. L: Ascaris lumbricoides, S. S: Strongyloides stercoralis